Takeda Pharmaceutical
TAK
#452
Rank
HK$415.66 B
Marketcap
HK$124.91
Share price
-1.54%
Change (1 day)
26.34%
Change (1 year)

Market capitalization of Takeda Pharmaceutical (TAK)

Market cap: HK$415.66 Billion

As of January 2026 Takeda Pharmaceutical has a market cap of HK$415.66 Billion. This makes Takeda Pharmaceutical the world's 452th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Takeda Pharmaceutical from 2008 to 2026

End of year Market Cap

Year Marketcap Change
2026HK$415.66 B2.58%
2025HK$405.21 B23.95%
2024HK$326.91 B-7.09%
2023HK$351.87 B-7.14%
2022HK$378.95 B13.78%
2021HK$333.04 B-24.52%
2020HK$441.26 B-8.57%
2019HK$482.61 B134.93%
2018HK$205.42 B-40.64%
2017HK$346.04 B36.98%
2016HK$252.62 B-17.64%
2015HK$306.73 B19.76%
2014HK$256.11 B-9.02%
2013HK$281.49 B2.61%
2012HK$274.33 B1.46%
2011HK$270.37 B-9.62%
2010HK$299.16 B18.93%
2009HK$251.55 B-28.92%
2008HK$353.90 B

End of Day market cap according to different sources

On Jan 13th, 2026 the market cap of Takeda Pharmaceutical was reported to be:

HK$393.00 Billion
by Nasdaq info icon info icon
HK$415.66 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
HK$4.016 T 866.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$892.19 B 114.64%๐Ÿ‡ซ๐Ÿ‡ท France
Pfizer
PFE
HK$1.115 T 168.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$2.119 T 410.01%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Seagen
SGEN
HK$336.69 B-19.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Dr. Reddy's Laboratories
RDY
HK$85.91 B-79.33%๐Ÿ‡ฎ๐Ÿ‡ณ India
Amgen
AMGN
HK$1.362 T 227.77%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
HK$786.83 B 89.29%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
HK$2.109 T 407.55%๐Ÿ‡บ๐Ÿ‡ธ USA